
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Temporal relationship between osteoarthritis and comorbidities: a combined case control and cohort study in the UK primary care setting”, Rheumatology (Oxford), 2021.
, , , “Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs”, Rheumatology (Oxford), 2020.
, , , , ,
“Predictors and temporal trend of flu vaccination in auto-immune rheumatic diseases in the UK: a nationwide prospective cohort study”, Rheumatology (Oxford), vol. 57, pp. 1726-1734, 2018.
, “Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from Clinical Practice Research Datalink”, Rheumatology (Oxford), vol. 57, pp. 977-981, 2018.
, “Urate-lowering treatment and risk of total joint replacement in patients with gout”, Rheumatology (Oxford), vol. 57, pp. 2129-2139, 2018.
, “Early Clinical Features in Systemic Lupus Erythematosus: Can They Be Used to Achieve Earlier Diagnosis? A Risk Prediction Model”, Arthritis Care Res (Hoboken), vol. 69, pp. 833-841, 2017.
, “Rheumatoid arthritis is getting less frequent-results of a nationwide population-based cohort study”, Rheumatology (Oxford), vol. 56, pp. 736-744, 2017.
, “Burden of Comorbidity in Systemic Lupus Erythematosus in the UK, 1999-2012”, Arthritis Care Res (Hoboken), vol. 68, pp. 819-27, 2016.
, “Comorbidities in patients with gout prior to and following diagnosis: case-control study”, Ann Rheum Dis, vol. 75, pp. 210-7, 2016.
, “Impact of gout on the risk of atrial fibrillation”, Rheumatology (Oxford), vol. 55, pp. 721-8, 2016.
, “The incidence and prevalence of systemic lupus erythematosus in the UK, 1999-2012”, Ann Rheum Dis, vol. 75, pp. 136-41, 2016.
, “Mortality in systemic lupus erythematosus in the United Kingdom 1999-2012”, Rheumatology (Oxford), vol. 55, pp. 854-60, 2016.
, “Effect of allopurinol on all-cause mortality in adults with incident gout: propensity score-matched landmark analysis”, Rheumatology (Oxford), vol. 54, pp. 2145-50, 2015.
, “Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study”, Ann Rheum Dis, vol. 74, pp. 661-7, 2015.
,